Table 5.
Number of patients experiencing common adverse Events (>1% of Population)
| Preferred Term | HMWHA | XLHA |
|---|---|---|
| N = 146 (%) | N = 139 (%) | |
| Diarrhoea | 3 (2.1) | 1 (0.7) |
| Dyspepsia | 1 (0.7) | 2 (1.4) |
| Injection site pruritus | 2 (1.4) | 1 (0.7) |
| Pain | 1 (0.7) | 4 (2.9) |
| Pyrexia | 0 (0) | 3 (2.2) |
| Cystitis | 2 (1.4) | 2 (1.4) |
| Nasopharyngitis | 3 (2.1) | 7 (5) |
| Upper respiratory tract infection | 0 (0) | 3 (2.2) |
| Joint swelling | 0 (0) | 2 (1.4) |
| Musculoskeletal pain | 0 (0) | 2 (1.4) |
| Pain in extremity | 6 (4.1) | 3 (2.2) |
| Plantar fasciitis | 0 (0) | 2 (1.4) |
| Headache | 5 (3.4) | 1 (0.7) |
| Paraesthesia | 0 (0) | 2 (1.4) |
| Cough | 3 (2.1) | 0 (0) |
| Erythema | 0 (0) | 2 (1.4) |